ProBio News and Resources

ProBio, a global CDMO, has announced the launch of its GMP plasmid DNA manufacturing service at its Hopewell facility. The new offering enables the delivery of clinical-grade plasmid DNA from cell bank to batch release in just three months, which

ProBio, a global contract development and manufacturing organisation (CDMO), has announced a strategic leadership reshuffle effective 1 December 2024. Allen Guo will serve as Chief Executive Officer, Whitney Winters as Senior Vice President of U.S. Business Development, and Michael Vreeland